Öznur Bal - Publications, H-index & Citations

Öznur Bal

city hospital ankara

13H指数

141论文数

580被引数

收录论文 20

发表时间

Prognostic Value of Baseline Metabolic Tumor Volume on [¹⁸F]FDG PET/CT in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors 基线代谢肿瘤体积在[¹⁸F]FDG PET/CT中预测接受CDK4/6抑制剂治疗的转移性乳腺癌的预后价值

Clinical Breast Cancer

IF2.5

2026-09-20

PREAI

Seyma Erdogan; Yusufcan Yılmaz; Elif Reyhan Aslan; Refia Yukselturk; Efnan Algın; Berna Okudan; Osman Inan; Oznur Bal

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501)切除后胆道癌的辅助化疗方案：国家性、比较性、观察性研究（TOG/GI-SAFRADJU-2501）

International Journal of Cancer

IF4.7

2026-08-15

OAAI

Erman Akkus; Mehmet Kayaalp; Müzeyyen Aslı Ergözoğlu; Ilgın Koç Kuş; Doğan Bayram; Bilgeşah Kılıçtaş; Emel Ayvaz Güneyin; Ali Kalem; Haydar Temizyürek; Mehmet Mutlu Çatlı; Mehmet Sinan Akarca; Maral Martin Mıldanoğlu; Görkem Turhan; Mahmut Kara; Hacı Arak; Feyza Arslan Tan; Burak Paçacı; Berkay Yeşilyurt; Orhun Akdoğan; Emine Bihter Çetin; Selahattin Çelik; Fatma Keskin Uzundere; Elif Şahin; Zehra Sadak Öcal; Lamia Şeker Can; Bahadır Köylü; Mehmet Cem Fidan; Esmanur Kaplan Tüzün; Teoman Şakalar; Elif Sertesen Çamöz; Haydar Çağatay Yüksel; Onur Yazdan Balçık; Pınar Peker; Mehmet Yılmaz; Şeymanur Ala Enli; Erdem Kölemen; Sibel Oyucu Orhan; Yakup Düzköprü; Mustafa Ersoy; Tuğba Akın Telli; Mesut Yılmaz; Yusuf İlhan; Atila Yıldırım; Ramazan Coşar; Müslih Ürün; Arif Hakan Önder; Murat Araz; Ertuğrul Bayram; Havva Yeşil Çınkır; Ali Alkan; Mustafa Gürbüz; Nilüfer Avcı; Fatma Paksoy Türköz; İsmail Oğuz Kara; Fatih Köse; İlkay Tuğba Ünek; Ahmet Bilici; Öznur Bal; Şuayib Yalçın; Lorenza Rimassa; Hatime Arzu Yaşar

Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Assessment of IDH1 Mutation: A Two-Center Retrospective Study IDH1突变评估的肝内胆管癌临床病理特征：一项多中心回顾性研究

Journal of Clinical Medicine

IF2.9

2026-07-07

OAAI

Muge Buyukaksoy; Selin Akturk Esen; Nesrin Turhan; Enes Seyda Sahiner; Imdat Eroglu; Aysenur Sert; Ugur Ozberk; Denizcan Hasturk; Oznur Bal; Efnan Algin; Sebnem Yucel; Nuriye Ozdemir; Onur Ertunc; Dogan Uncu

Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer 低肌肉质量预示晚期卵巢癌对新辅助化疗的不良反应

Journal of Ovarian Research

IF4.2

2026-06-16

OAAI

Derya Demirtaş Esmer; Emre Hafızoğlu; Murat Bardakçı; Erdem Özkan; Serhat Sekmek; Doğan Bayram; İrfan Karahan; Efnan Algın; Öznur Bal

CANT1 as a novel prognostic biomarker in triple-negative breast cancer CANT1作为三阴性乳腺癌的新型预后生物标志物

Oncology Letters

IF2.2

2026-05-01

PREAI

Bayram, Dogan; Colak, Aysel; Karabulut, Sefika; Ozsan Celebi, Sema Nur; Hafizoglu, Emre; Turkay, Duriye Ozer; Bal, Oznur; Algin, Efnan; Yucel, Sebnem; Sendur, Mehmet Ali Nahit; Civelek, Burak; Ucar, Gokhan

A Machine Learning Framework for Prognostic Modeling in Stage III Colon Cancer 机器学习框架在III期结直肠癌预后建模中的应用

Journal of Clinical Medicine

IF2.9

2026-04-18

OAAI

Rümeysa Sungur; Selin Aktürk Esen; Hilal Arslan; Sevil Uygun İlikhan; Hatice Rüveyda Akça; Efnan Algın; Öznur Bal; Şebnem Yaman; Doğan Uncu

Machine learning–based prediction of recurrence after curative resection in non–small cell lung cancer 基于机器学习的非小细胞肺癌根治性切除术后复发预测

Scientific Reports

IF3.9

2026-04-09

OAAI

Ugur Ozberk; Selin Akturk Esen; Hilal Arslan; Oznur Bal; Efnan Algın; Serkan Keskin; Burak Bilgin; Melike Cobankaya; Mehmet Ali Nahit Sendur; Dogan Uncu

Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG)在HER2阳性转移性乳腺癌中达到“无疾病证据”的临床意义：土耳其肿瘤学组（TOG）开展的多中心研究

Cancers

IF4.4

2026-03-12

OAAI

Bengü Dursun; Şendağ Yaslıkaya; Serhat Sekmek; Tuğba Önder; Hasan Çağrı Yıldırım; Ömer Acar; Nadiye Sever; Savaş Gökçek; Sercan Ön; Ferit Aslan; Gül Sema Keskin; Zehra Sucuoğlu İşleyen; Gözde Savaş; Mehmet Emin Kalender; Semra Paydaş; Öznur Bal; Ülkü Yalçıntaş Arslan; Mustafa Şahbazlar; Burcu Çakar; Hacı Mehmet Türk; Hakan Akbulut

Clinicopathologic Disease Characteristics and Their Association with Adjuvant Chemotherapy Outcomes in Pulmonary Large-Cell Carcinoma Patients with or Without Neuroendocrine Features 肺大细胞癌伴或不伴神经内分泌特征的患者的临床病理疾病特征及其与辅助化疗结局的关联

Diagnostics

IF3.3

2026-03-03

OAAI

Doğan Bayram; Oznur Bal; Efe Cem Erdat; Serhat Sekmek; Saliha Yılmaz; Perihan Perkin; Süleyman Gökalp Güneş; Efnan Algin; Bülent Mustafa Yenigün

Bridging East and West: Real-World Clinicogenomic Landscape of Metastatic NSCLC in Türkiye 连接东西方：土耳其转移性非小细胞肺癌的真实世界临床基因组学景观

Genes 2025, Vol. 16, Page 1446

IF2.8

2025-12-03

OAAI

Kübra Canaslan; Emre Eken; Mehmet Bilici; Fahriye Merve Balcıoğlu; Banu Öztürk; Mehmet Çakmak; Öznur Bal; Görkem Turhan; Feyyaz Özdemir; Hayati Arvas; Zuhat Urakçı; Ebru Çiçek; Zeynep Hande Turna; Aziz Karaoğlu

Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter 老年男性新发转移性激素敏感性前列腺癌：治疗及合并症是否重要

MEDICINA-LITHUANIA

IF2.4

2025-11-20

OAAI

Ozberk, Ugur; Esen, Selin Akturk; Uguz, Alican; Algin, Efnan; Bal, Oznur; Akinci, Bulent; Uncu, Dogan

Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study 抗VEGF和抗EGFRs在微卫星不稳定（MSI-H）转移性结直肠癌中的疗效：土耳其肿瘤学组（TOG）队列研究

Current Oncology 2025, Vol. 32, Page 639

IF3.4

2025-11-18

OAAI

İlknur Deliktaş Onur; Mutlu Doğan; Mehmet Akif Öztürk; Taha Koray Sahin; Murat Kiracı; Ahmet Melih Arslan; Eda Karapelit; Bahar Beliz Karaoğlan; Nargiz Majidova; Elif Şahin; Sabin Göktaş; Abdullah Sakin; Ali Oğul; Emine Türkmen; Kadriye Başkurt; Zeynep Yüksel Yaşar; Yakup Ergün; Esma Türkmen Bekmez; Şafak Yıldırım Dişli; Sinem Akbaş; Sema Türker; Ömer Dizdar; Öznur Bal; Tuğba Yavuzşen; Melek Karakurt; Arzu Hatime Yaşar; Tuğba Başoğlu; Faysal Dane; Şuayip Yalçın; Öztürk Ateş

Women’s adherence to medication and hope in the presence of another chronic disease besides breast cancer: a cross-sectional study 女性对药物的依从性以及在除乳腺癌外存在其他慢性疾病情况下的希望：一项横断面研究

Supportive Care in Cancer

IF3

2025-09-22

PREAI

Figen Akay; Ayşe Özkaraman; Öznur Bal

Palbociclib in liposarcoma: real-world multicenter data from the Turkish Oncology Group (TOG)帕博西利在脂肪肉瘤中的应用：土耳其肿瘤学组（TOG）的真实世界多中心数据

JOURNAL OF CHEMOTHERAPY

IF1.8

2025-09-01

PREAI

Kus, Fatih; Yildirim, Hasan Cagri; Bayram, Dogan; Bal, Oznur; Sahin, Gokhan; Ugrakli, Muzaffer; Demiray, Atike Gokcen; Alan, Ozkan; Koc Kus, Ilgin; Sirvan, Firat; Yildirim, Nilgun; Unal, Olcun Umit; Yaslikaya, Sendag; Sahin, Elif; Sakalar, Teoman; Atalah, Fatih; Karhan, Ogur; Enki, Serkan; Kilickap, Saadettin; Akin, Serkan

Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis 肛直肠恶性黑色素瘤：单中心回顾性分析的诊疗误区与预后启示

Diagnostics 2025, Vol. 15, Page 2086

IF3.3

2025-08-23

PREAI

Emre Hafızoğlu; Murat Bardakçı; Yakup Ergun; Irfan Karahan; Doğan Bayram; Fahriye Tugba Kos; Efnan Algın; Oznur Bal; Dogan Uncu

Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity?

EXPERT OPINION ON DRUG SAFETY

IF3.1

2021-03-05

PREAI

Acikgoz, Yusuf; Bal, Oznur; Ucar, Gokhan; Durnali, Ayse; Ergun, Yakup; Dirikoc, Merve; Esen, Selin Akturk; Dogan, Mutlu

Is there any correlation among MKK4(mitogen-activated protein kinase kinase 4)expression, clinicopathological features, and KRAS/NRAS mutation in colorectal cancer

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2020-07-13

PREAI

Dogan, Mutlu; Guresci, Servet; Acikgoz, Yusuf; Ergun, Yakup; Kos, Fahriye Tugba; Bozdogan, Onder; Bal, Oznur

KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2019-11-19

PREAI

Ergun, Yakup; Acikgoz, Yusuf; Bal, Oznur; Ucar, Gokhan; Dirikoc, Merve; Yildirim, Eda Caliskan; Akdeniz, Nadiye; Uncu, Dogan

Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab 曲妥珠单抗辅助治疗HER2阳性早期乳腺癌患者脑转移作为疾病复发的第一部位的危险因素

BREAST

IF7.9

2016-02-01

PREAI

Tonyali, Onder; Coskun, Ugur; Yuksel, Sinemis; Inanc, Mevlude; Bal, Oznur; Akman, Tulay; Yazilitas, Dogan; Ulas, Arife; Kucukoner, Mehmet; Aksoy, Asude; Demirci, Umut; Uysal, Mukremin; Tanriverdi, Ozgur; Gunaydin, Yusuf; Sumbul, Ahmet Taner; Yildiz, Ramazan; Karaca, Halit; Oksuzoglu, Berna; Ciltas, Aydin; Buyukberber, Suleyman; Benekli, Mustafa

The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fluorouracil (mDCF) regimen

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-01

PREAI

Yazici, O.; Ozdemir, N.; Erel, O.; Demirci, N. S.; Aksoy, S.; Sendur, M. A. N.; Dogan, M.; Yazilitas, D.; Erdem, G. U.; Neselioglu, S.; Hocazade, C.; Bozkaya, Y.; Bal, O.; Zengin, N.

研究方向